Welcome to IsraPharm - Contact us at +972 7337 468 45 (Office)

Contact Us

Office Address

Weizman 14 st., Tel Aviv, Israel

Phone Number

+972 7337 46845 (Office)

Email Address

[email protected]

Perjeta

$3,499.00

In Stock

-
+
Add to Wishlist
Add to Wishlist

Description

Perjeta.
Metastatic breast cancer
In combination with trastuzumab and docetaxel for metastatic or locally recurrent, inoperable breast cancer with tumor overexpression of HER2 in the absence of previous HER2-specific therapy or chemotherapy for metastatic disease.
Non-metastatic breast cancer
In combination with trastuzumab and chemotherapy:
as a neoadjuvant therapy for locally advanced, edematous infiltrative or early (primary operable) breast cancer (tumor diameter more than 2 cm or with lymph node involvement) with HER2 overexpression as part of a complete treatment regimen for early breast cancer;
as an adjuvant therapy for early (primary operable) breast cancer with HER2 overexpression.

Active ingredient: pertuzumab

Storage temperature 4-8 degrees

Prescription medicine